全文获取类型
收费全文 | 16333篇 |
免费 | 910篇 |
国内免费 | 175篇 |
专业分类
耳鼻咽喉 | 177篇 |
儿科学 | 445篇 |
妇产科学 | 354篇 |
基础医学 | 1742篇 |
口腔科学 | 514篇 |
临床医学 | 1289篇 |
内科学 | 4286篇 |
皮肤病学 | 308篇 |
神经病学 | 1640篇 |
特种医学 | 784篇 |
外科学 | 2793篇 |
综合类 | 46篇 |
一般理论 | 4篇 |
预防医学 | 546篇 |
眼科学 | 213篇 |
药学 | 874篇 |
中国医学 | 18篇 |
肿瘤学 | 1385篇 |
出版年
2024年 | 14篇 |
2023年 | 201篇 |
2022年 | 402篇 |
2021年 | 742篇 |
2020年 | 439篇 |
2019年 | 548篇 |
2018年 | 653篇 |
2017年 | 508篇 |
2016年 | 525篇 |
2015年 | 611篇 |
2014年 | 717篇 |
2013年 | 872篇 |
2012年 | 1328篇 |
2011年 | 1292篇 |
2010年 | 720篇 |
2009年 | 675篇 |
2008年 | 1048篇 |
2007年 | 960篇 |
2006年 | 865篇 |
2005年 | 830篇 |
2004年 | 742篇 |
2003年 | 615篇 |
2002年 | 575篇 |
2001年 | 166篇 |
2000年 | 148篇 |
1999年 | 139篇 |
1998年 | 104篇 |
1997年 | 79篇 |
1996年 | 81篇 |
1995年 | 74篇 |
1994年 | 52篇 |
1993年 | 52篇 |
1992年 | 71篇 |
1991年 | 61篇 |
1990年 | 63篇 |
1989年 | 47篇 |
1988年 | 43篇 |
1987年 | 48篇 |
1986年 | 32篇 |
1985年 | 36篇 |
1984年 | 29篇 |
1983年 | 14篇 |
1979年 | 31篇 |
1978年 | 11篇 |
1977年 | 15篇 |
1976年 | 17篇 |
1975年 | 18篇 |
1974年 | 11篇 |
1971年 | 10篇 |
1968年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
Luca Boeri Federico Belladelli Paolo Capogrosso Walter Cazzaniga Luigi Candela Edoardo Pozzi Luca Valsecchi Enrico Papaleo Paola Viganò Costantino Abbate Filippo Pederzoli Massimo Alfano Francesco Montorsi Andrea Salonia 《Andrologia》2021,53(1):e13861
A proportion of men are infertile despite having normal medical history/physical examination and normal semen analysis. We aimed to assess whether normal sperm parameters per se account for male factor fertility. 1,957 infertile men were compared with 103 age-comparable fertile controls. Semen analysis was based on 2010 World Health Organization reference criteria. Of all, 12.1% of infertile men and 40.8% of fertile men presented with normal sperm parameters. Among fertile men, 36.9% had isolated sperm abnormalities and 22.3% men showed two or more concomitant sperm abnormalities. Serum total testosterone was higher in infertile men with normal sperm parameters compared to those with ≥2 sperm abnormalities or azoospermia, but similar to those with isolated sperm abnormalities (p ≤ .001). Circulating hormones were similar among sperm parameters groups in fertile men. At multivariable analyses, testicular volume (OR 1.12, p ≤ .001) and FSH (OR 0.8, p ≤ .001) were associated with normal sperm parameters. Overall, the longer the infertility period, the greater the number of sperm parameters abnormalities (p < .01). In conclusion, we found that 12% of infertile men and only 41% of fertile men present with normal sperm parameters. Normal sperm parameters per se do not reliably account for fertility in the real-life setting. 相似文献
73.
Ricciardi Luca Stifano Vito Pucci Resi Stumpo Vittorio Montano Nicola Della Monaca Marco Lauretti Liverana Olivi Alessandro Valentini Valentino Sturiale Carmelo Lucio 《Neurosurgical review》2021,44(1):153-161
Neurosurgical Review - The surgical injury of the intracranial portion of the facial nerve (FN) is a severe complication of many skull base procedures, and it represents a relevant issue in terms... 相似文献
74.
Luca M. Sconfienza Domenico Albano Carmelo Messina Rocco D’Apolito Elena De Vecchi Luigi Zagra 《The Journal of arthroplasty》2021,36(8):2962-2967
BackgroundTo diagnose periprosthetic joint infection (PJI) preoperatively, ultrasound-guided joint aspiration (US-JA) may not be performed when effusion is minimal or absent. We aimed to report and investigate the diagnostic performance of ultrasound-guided periprosthetic biopsy (US-PB) of synovial tissue to obtain joint samples in patients without fluid around the implants.MethodsOne-hundred nine patients (55 men; mean age: 68 ± 13 years) with failed total hip arthroplasty (THA) who underwent revision surgery performed preoperative US-JA or US-PB to rule out PJI.ResultsSixty-nine of 109 patients had joint effusion and underwent US-JA, while the remaining 40 with dry joint required US-PB. Thirty-five of 109 patients (32.1%) had PJI, while 74/109 (67.9%) had aseptic THA failure. No immediate complications were observed in both groups. Technical success of US-PB was 100%, as the procedure was carried on as planned in all cases. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of US-JA were 52.2%, 97.8%, 92.3%, 80.3%, and 82.6%, while for US-PB, they were 41.7%, 100%, 100%, 80%, and 82.5%, respectively, with no significant difference (P = .779). Using the final diagnosis as reference standard, we observed a moderate agreement with both US-JA (k = 0.56) and US-PB (k = 0.50).ConclusionWe present a novel US-guided technique to biopsy periprosthetic synovial tissue of failed THA to rule out PJI. We found similar diagnostic performance as compared with traditional US-JA. This supports future larger studies on this procedure that might be applied in patients without joint effusion. 相似文献
75.
Luca Degli Esposti Valentina Perrone Diego Sangiorgi Margherita Andretta Fausto Bartolini Arturo Cavaliere Andrea Ciaccia Stefania Dell'orco Stefano Grego Sara Salzano Loredana Ubertazzo Adriano Vercellone Davide Gatti Angelo Fassio Ombretta Viapiana Maurizio Rossini Giovanni Adami 《Journal of bone and mineral research》2021,36(11):2177-2183
The determinants of the susceptibility to severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection and severe coronavirus disease 2019 (COVID-19) manifestations are yet not fully understood. Amino-bisphosphonates (N-BPs) have anti-inflammatory properties and have been shown to reduce the incidence of lower respiratory infections, cardiovascular events, and cancer. We conducted a population-based retrospective observational cohort study with the primary objective of determining if oral N-BPs treatment can play a role in the susceptibility to development of severe COVID-19. Administrative International Classification of Diseases, Ninth Revision, Clinical ModificationI (ICD-9-CM) and anatomical-therapeutic chemical (ATC) code data, representative of Italian population (9% sample of the overall population), were analyzed. Oral N-BPs (mainly alendronate and risedronate) were included in the analysis, zoledronic acid was excluded because of the low number of patients at risk. Incidence of COVID-19 hospitalization was 12.32 (95% confidence interval [CI], 9.61–15.04) and 11.55 (95% CI, 8.91–14.20), of intensive care unit (ICU) utilization because of COVID-19 was 1.25 (95% CI, 0.38–2.11) and 1.42 (95% CI, 0.49–2.36), and of all-cause death was 4.06 (95% CI, 2.50–5.61) and 3.96 (95% CI, 2.41–5.51) for oral N-BPs users and nonusers, respectively. Sensitivity analyses that excluded patients with prevalent vertebral or hip fragility fractures and without concomitant glucocorticoid treatment yielded similar results. In conclusion, we found that the incidence of COVID-19 hospitalization, intensive care unit (ICU) utilization, and COVID-19 potentially related mortality were similar in N-BPs–treated and nontreated subjects. Similar results were found in N-BPs versus other anti-osteoporotic drugs. We provide real-life data on the safety of oral N-BPs in terms of severe COVID-19 risk on a population-based cohort. Our results do not support the hypothesis that oral N-BPs can prevent COVID-19 infection and/or severe COVID-19; however, they do not seem to increase the risk. © 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). 相似文献
76.
Edoardo Conticini Paolo Falsetti Marco Bardelli Luca Cantarini Bruno Frediani 《Reumatologia》2021,59(2):121
Giant cell arteritis (GCA) is a large-vessel vasculitis, typically affecting the aorta and its branches. The involvement of vertebral and internal carotid arteries occurs in a limited number of cases, and stroke as a presenting symptom of GCA is extremely unusual: this subset of the disease has a poor prognosis and rarely responds to immunosuppression.We report the case of a 70-year-old woman, who presented to the Emergency Department for ischemic stroke, which appeared to be the first and only symptom of GCA. The prompt administration of steroids and tocilizumab (TCZ) led to clinical and radiological resolution, with no residual disability at 6-month follow-up.Our case-based review, highlighting the rarity of a large vessel vasculitis presenting only with a cerebrovascular accident, provides new evidence for the efficacy of TCZ even in more unusual varieties of GCA: in these cases, TCZ should be immediately prescribed, in order to prevent mortality and severe long-term morbidity. 相似文献
77.
78.
Suzanne M Jan de Beur Paul D Miller Thomas J Weber Munro Peacock Karl Insogna Rajiv Kumar Frank Rauch Diana Luca Tricia Cimms Mary Scott Roberts Javier San Martin Thomas O Carpenter 《Journal of bone and mineral research》2021,36(4):627-635
Tumor-induced osteomalacia (TIO) is caused by phosphaturic mesenchymal tumors producing fibroblast growth factor 23 (FGF23) and is characterized by impaired phosphate metabolism, skeletal health, and quality of life. UX023T-CL201 is an ongoing, open-label, phase 2 study investigating the safety and efficacy of burosumab, a fully human monoclonal antibody that inhibits FGF23, in adults with TIO or cutaneous skeletal hypophosphatemia syndrome (CSHS). Key endpoints were changes in serum phosphorus and osteomalacia assessed by transiliac bone biopsies at week 48. This report focuses on 14 patients with TIO, excluding two diagnosed with X-linked hypophosphatemia post-enrollment and one with CSHS. Serum phosphorus increased from baseline (0.52 mmol/L) and was maintained after dose titration from week 22 (0.91 mmol/L) to week 144 (0.82 mmol/L, p < 0.0001). Most measures of osteomalacia were improved at week 48: osteoid volume/bone, osteoid thickness, and mineralization lag time decreased; osteoid surface/bone surface showed no change. Of 249 fractures/pseudofractures detected across 14 patients at baseline, 33% were fully healed and 13% were partially healed at week 144. Patients reported a reduction in pain and fatigue and an increase in physical health. Two patients discontinued: one to treat an adverse event (AE) of neoplasm progression and one failed to meet dosing criteria (receiving minimal burosumab). Sixteen serious AEs occurred in seven patients, and there was one death; all serious AEs were considered unrelated to treatment. Nine patients had 16 treatment-related AEs; all were mild to moderate in severity. In adults with TIO, burosumab exhibited an acceptable safety profile and was associated with improvements in phosphate metabolism and osteomalacia. © 2020 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research.. 相似文献
79.
La Mendola Roberta Bencivenga Maria Torroni Lorena Alberti Luca Sacco Michele Casella Francesco Ridolfi Cecilia Simoni Nicola Micera Renato Pavarana Michele Verlato Giuseppe Giacopuzzi Simone 《Annals of surgical oncology》2021,28(6):3034-3043
Annals of Surgical Oncology - Although pathological complete response (pCR) after multimodal treatment for esophageal cancer is associated to the best prognosis, recurrence may occur in... 相似文献
80.